nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—CYP1A2—Sorafenib—thyroid cancer	0.0455	0.43	CbGbCtD
Betaxolol—CYP2D6—Sorafenib—thyroid cancer	0.0375	0.355	CbGbCtD
Betaxolol—CYP2D6—Doxorubicin—thyroid cancer	0.0227	0.215	CbGbCtD
Betaxolol—Dyspepsia—Sorafenib—thyroid cancer	0.00141	0.00157	CcSEcCtD
Betaxolol—Decreased appetite—Sorafenib—thyroid cancer	0.00139	0.00155	CcSEcCtD
Betaxolol—Thrombophlebitis—Epirubicin—thyroid cancer	0.00139	0.00155	CcSEcCtD
Betaxolol—Mouth ulceration—Doxorubicin—thyroid cancer	0.00138	0.00155	CcSEcCtD
Betaxolol—Bladder pain—Doxorubicin—thyroid cancer	0.00138	0.00155	CcSEcCtD
Betaxolol—Diabetes mellitus—Epirubicin—thyroid cancer	0.00138	0.00154	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00138	0.00154	CcSEcCtD
Betaxolol—Fatigue—Sorafenib—thyroid cancer	0.00138	0.00154	CcSEcCtD
Betaxolol—Pain—Sorafenib—thyroid cancer	0.00137	0.00153	CcSEcCtD
Betaxolol—Constipation—Sorafenib—thyroid cancer	0.00137	0.00153	CcSEcCtD
Betaxolol—Vascular purpura—Epirubicin—thyroid cancer	0.00134	0.0015	CcSEcCtD
Betaxolol—Hypertonia—Doxorubicin—thyroid cancer	0.00134	0.0015	CcSEcCtD
Betaxolol—Eczema—Epirubicin—thyroid cancer	0.00134	0.00149	CcSEcCtD
Betaxolol—Abnormal vision—Doxorubicin—thyroid cancer	0.00133	0.00149	CcSEcCtD
Betaxolol—Eye pain—Epirubicin—thyroid cancer	0.00133	0.00149	CcSEcCtD
Betaxolol—Mental disability—Doxorubicin—thyroid cancer	0.00133	0.00149	CcSEcCtD
Betaxolol—Lymphadenopathy—Doxorubicin—thyroid cancer	0.0013	0.00146	CcSEcCtD
Betaxolol—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00128	0.00144	CcSEcCtD
Betaxolol—Increased appetite—Epirubicin—thyroid cancer	0.00128	0.00143	CcSEcCtD
Betaxolol—Diabetes mellitus—Doxorubicin—thyroid cancer	0.00128	0.00143	CcSEcCtD
Betaxolol—Urticaria—Sorafenib—thyroid cancer	0.00127	0.00142	CcSEcCtD
Betaxolol—Body temperature increased—Sorafenib—thyroid cancer	0.00126	0.00141	CcSEcCtD
Betaxolol—Renal impairment—Epirubicin—thyroid cancer	0.00126	0.00141	CcSEcCtD
Betaxolol—Purpura—Epirubicin—thyroid cancer	0.00125	0.00139	CcSEcCtD
Betaxolol—Vascular purpura—Doxorubicin—thyroid cancer	0.00124	0.00139	CcSEcCtD
Betaxolol—Eczema—Doxorubicin—thyroid cancer	0.00124	0.00138	CcSEcCtD
Betaxolol—Eye pain—Doxorubicin—thyroid cancer	0.00123	0.00138	CcSEcCtD
Betaxolol—Cardiac failure—Epirubicin—thyroid cancer	0.00123	0.00138	CcSEcCtD
Betaxolol—Hypoglycaemia—Epirubicin—thyroid cancer	0.00123	0.00138	CcSEcCtD
Betaxolol—Lethargy—Epirubicin—thyroid cancer	0.00123	0.00137	CcSEcCtD
Betaxolol—Osteoarthritis—Epirubicin—thyroid cancer	0.0012	0.00134	CcSEcCtD
Betaxolol—Increased appetite—Doxorubicin—thyroid cancer	0.00118	0.00132	CcSEcCtD
Betaxolol—Affect lability—Epirubicin—thyroid cancer	0.00118	0.00132	CcSEcCtD
Betaxolol—Hypersensitivity—Sorafenib—thyroid cancer	0.00118	0.00132	CcSEcCtD
Betaxolol—Renal impairment—Doxorubicin—thyroid cancer	0.00117	0.00131	CcSEcCtD
Betaxolol—Purpura—Doxorubicin—thyroid cancer	0.00115	0.00129	CcSEcCtD
Betaxolol—Asthenia—Sorafenib—thyroid cancer	0.00115	0.00128	CcSEcCtD
Betaxolol—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00114	0.00127	CcSEcCtD
Betaxolol—Cardiac failure—Doxorubicin—thyroid cancer	0.00114	0.00127	CcSEcCtD
Betaxolol—Mood swings—Epirubicin—thyroid cancer	0.00114	0.00127	CcSEcCtD
Betaxolol—Lethargy—Doxorubicin—thyroid cancer	0.00113	0.00127	CcSEcCtD
Betaxolol—Pruritus—Sorafenib—thyroid cancer	0.00113	0.00126	CcSEcCtD
Betaxolol—Ataxia—Epirubicin—thyroid cancer	0.00113	0.00126	CcSEcCtD
Betaxolol—Osteoarthritis—Doxorubicin—thyroid cancer	0.00111	0.00124	CcSEcCtD
Betaxolol—Affect lability—Doxorubicin—thyroid cancer	0.00109	0.00122	CcSEcCtD
Betaxolol—Hypokalaemia—Epirubicin—thyroid cancer	0.00109	0.00122	CcSEcCtD
Betaxolol—Diarrhoea—Sorafenib—thyroid cancer	0.00109	0.00122	CcSEcCtD
Betaxolol—Breast disorder—Epirubicin—thyroid cancer	0.00109	0.00121	CcSEcCtD
Betaxolol—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00108	0.00121	CcSEcCtD
Betaxolol—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00108	0.00121	CcSEcCtD
Betaxolol—Nasopharyngitis—Epirubicin—thyroid cancer	0.00107	0.0012	CcSEcCtD
Betaxolol—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00106	0.00118	CcSEcCtD
Betaxolol—Dizziness—Sorafenib—thyroid cancer	0.00106	0.00118	CcSEcCtD
Betaxolol—Mood swings—Doxorubicin—thyroid cancer	0.00105	0.00118	CcSEcCtD
Betaxolol—Ataxia—Doxorubicin—thyroid cancer	0.00104	0.00117	CcSEcCtD
Betaxolol—Influenza—Epirubicin—thyroid cancer	0.00104	0.00116	CcSEcCtD
Betaxolol—Dysphagia—Epirubicin—thyroid cancer	0.00104	0.00116	CcSEcCtD
Betaxolol—Asthma—Epirubicin—thyroid cancer	0.00104	0.00116	CcSEcCtD
Betaxolol—Vomiting—Sorafenib—thyroid cancer	0.00102	0.00114	CcSEcCtD
Betaxolol—Hypokalaemia—Doxorubicin—thyroid cancer	0.00101	0.00113	CcSEcCtD
Betaxolol—Angina pectoris—Epirubicin—thyroid cancer	0.00101	0.00113	CcSEcCtD
Betaxolol—Rash—Sorafenib—thyroid cancer	0.00101	0.00113	CcSEcCtD
Betaxolol—Dermatitis—Sorafenib—thyroid cancer	0.00101	0.00112	CcSEcCtD
Betaxolol—Breast disorder—Doxorubicin—thyroid cancer	0.001	0.00112	CcSEcCtD
Betaxolol—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.001	0.00112	CcSEcCtD
Betaxolol—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.001	0.00112	CcSEcCtD
Betaxolol—Headache—Sorafenib—thyroid cancer	0.001	0.00112	CcSEcCtD
Betaxolol—Bronchitis—Epirubicin—thyroid cancer	0.000998	0.00112	CcSEcCtD
Betaxolol—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000994	0.00111	CcSEcCtD
Betaxolol—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.00098	0.0011	CcSEcCtD
Betaxolol—Dysuria—Epirubicin—thyroid cancer	0.00097	0.00109	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000965	0.00108	CcSEcCtD
Betaxolol—Dysphagia—Doxorubicin—thyroid cancer	0.00096	0.00107	CcSEcCtD
Betaxolol—Asthma—Doxorubicin—thyroid cancer	0.00096	0.00107	CcSEcCtD
Betaxolol—Influenza—Doxorubicin—thyroid cancer	0.00096	0.00107	CcSEcCtD
Betaxolol—Nausea—Sorafenib—thyroid cancer	0.000949	0.00106	CcSEcCtD
Betaxolol—Weight increased—Epirubicin—thyroid cancer	0.000945	0.00106	CcSEcCtD
Betaxolol—Weight decreased—Epirubicin—thyroid cancer	0.000939	0.00105	CcSEcCtD
Betaxolol—Hyperglycaemia—Epirubicin—thyroid cancer	0.000936	0.00105	CcSEcCtD
Betaxolol—Angina pectoris—Doxorubicin—thyroid cancer	0.000935	0.00105	CcSEcCtD
Betaxolol—Pneumonia—Epirubicin—thyroid cancer	0.000931	0.00104	CcSEcCtD
Betaxolol—Infestation NOS—Epirubicin—thyroid cancer	0.000925	0.00103	CcSEcCtD
Betaxolol—Infestation—Epirubicin—thyroid cancer	0.000925	0.00103	CcSEcCtD
Betaxolol—Bronchitis—Doxorubicin—thyroid cancer	0.000924	0.00103	CcSEcCtD
Betaxolol—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000907	0.00101	CcSEcCtD
Betaxolol—Stomatitis—Epirubicin—thyroid cancer	0.000902	0.00101	CcSEcCtD
Betaxolol—Conjunctivitis—Epirubicin—thyroid cancer	0.000899	0.00101	CcSEcCtD
Betaxolol—Dysuria—Doxorubicin—thyroid cancer	0.000898	0.001	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000893	0.000998	CcSEcCtD
Betaxolol—Sweating—Epirubicin—thyroid cancer	0.000887	0.000992	CcSEcCtD
Betaxolol—Weight increased—Doxorubicin—thyroid cancer	0.000874	0.000977	CcSEcCtD
Betaxolol—Epistaxis—Epirubicin—thyroid cancer	0.000873	0.000976	CcSEcCtD
Betaxolol—Weight decreased—Doxorubicin—thyroid cancer	0.000869	0.000971	CcSEcCtD
Betaxolol—Sinusitis—Epirubicin—thyroid cancer	0.000868	0.000971	CcSEcCtD
Betaxolol—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000866	0.000969	CcSEcCtD
Betaxolol—Agranulocytosis—Epirubicin—thyroid cancer	0.000864	0.000966	CcSEcCtD
Betaxolol—Pneumonia—Doxorubicin—thyroid cancer	0.000861	0.000963	CcSEcCtD
Betaxolol—Infestation NOS—Doxorubicin—thyroid cancer	0.000856	0.000957	CcSEcCtD
Betaxolol—Infestation—Doxorubicin—thyroid cancer	0.000856	0.000957	CcSEcCtD
Betaxolol—Bradycardia—Epirubicin—thyroid cancer	0.000846	0.000946	CcSEcCtD
Betaxolol—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000839	0.000938	CcSEcCtD
Betaxolol—Stomatitis—Doxorubicin—thyroid cancer	0.000835	0.000933	CcSEcCtD
Betaxolol—Rhinitis—Epirubicin—thyroid cancer	0.000833	0.000931	CcSEcCtD
Betaxolol—Conjunctivitis—Doxorubicin—thyroid cancer	0.000832	0.000931	CcSEcCtD
Betaxolol—Hypoaesthesia—Epirubicin—thyroid cancer	0.000827	0.000924	CcSEcCtD
Betaxolol—Pharyngitis—Epirubicin—thyroid cancer	0.000824	0.000922	CcSEcCtD
Betaxolol—Sweating—Doxorubicin—thyroid cancer	0.000821	0.000918	CcSEcCtD
Betaxolol—Epistaxis—Doxorubicin—thyroid cancer	0.000808	0.000903	CcSEcCtD
Betaxolol—Sinusitis—Doxorubicin—thyroid cancer	0.000803	0.000898	CcSEcCtD
Betaxolol—Visual impairment—Epirubicin—thyroid cancer	0.000801	0.000895	CcSEcCtD
Betaxolol—Agranulocytosis—Doxorubicin—thyroid cancer	0.000799	0.000893	CcSEcCtD
Betaxolol—Bradycardia—Doxorubicin—thyroid cancer	0.000783	0.000875	CcSEcCtD
Betaxolol—Eye disorder—Epirubicin—thyroid cancer	0.000776	0.000868	CcSEcCtD
Betaxolol—Tinnitus—Epirubicin—thyroid cancer	0.000775	0.000866	CcSEcCtD
Betaxolol—Flushing—Epirubicin—thyroid cancer	0.000771	0.000862	CcSEcCtD
Betaxolol—Cardiac disorder—Epirubicin—thyroid cancer	0.000771	0.000862	CcSEcCtD
Betaxolol—Rhinitis—Doxorubicin—thyroid cancer	0.000771	0.000862	CcSEcCtD
Betaxolol—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000765	0.000855	CcSEcCtD
Betaxolol—Pharyngitis—Doxorubicin—thyroid cancer	0.000763	0.000853	CcSEcCtD
Betaxolol—Angiopathy—Epirubicin—thyroid cancer	0.000754	0.000843	CcSEcCtD
Betaxolol—Immune system disorder—Epirubicin—thyroid cancer	0.00075	0.000839	CcSEcCtD
Betaxolol—Mediastinal disorder—Epirubicin—thyroid cancer	0.000749	0.000837	CcSEcCtD
Betaxolol—Chills—Epirubicin—thyroid cancer	0.000745	0.000833	CcSEcCtD
Betaxolol—Arrhythmia—Epirubicin—thyroid cancer	0.000742	0.00083	CcSEcCtD
Betaxolol—Visual impairment—Doxorubicin—thyroid cancer	0.000741	0.000828	CcSEcCtD
Betaxolol—Alopecia—Epirubicin—thyroid cancer	0.000734	0.000821	CcSEcCtD
Betaxolol—Mental disorder—Epirubicin—thyroid cancer	0.000728	0.000814	CcSEcCtD
Betaxolol—Malnutrition—Epirubicin—thyroid cancer	0.000723	0.000809	CcSEcCtD
Betaxolol—Erythema—Epirubicin—thyroid cancer	0.000723	0.000809	CcSEcCtD
Betaxolol—Eye disorder—Doxorubicin—thyroid cancer	0.000718	0.000803	CcSEcCtD
Betaxolol—Tinnitus—Doxorubicin—thyroid cancer	0.000717	0.000801	CcSEcCtD
Betaxolol—Flushing—Doxorubicin—thyroid cancer	0.000713	0.000798	CcSEcCtD
Betaxolol—Cardiac disorder—Doxorubicin—thyroid cancer	0.000713	0.000798	CcSEcCtD
Betaxolol—Tension—Epirubicin—thyroid cancer	0.00071	0.000793	CcSEcCtD
Betaxolol—Dysgeusia—Epirubicin—thyroid cancer	0.000708	0.000792	CcSEcCtD
Betaxolol—Nervousness—Epirubicin—thyroid cancer	0.000702	0.000785	CcSEcCtD
Betaxolol—Angiopathy—Doxorubicin—thyroid cancer	0.000697	0.00078	CcSEcCtD
Betaxolol—Muscle spasms—Epirubicin—thyroid cancer	0.000695	0.000777	CcSEcCtD
Betaxolol—Immune system disorder—Doxorubicin—thyroid cancer	0.000694	0.000776	CcSEcCtD
Betaxolol—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000693	0.000775	CcSEcCtD
Betaxolol—Chills—Doxorubicin—thyroid cancer	0.00069	0.000771	CcSEcCtD
Betaxolol—Arrhythmia—Doxorubicin—thyroid cancer	0.000687	0.000768	CcSEcCtD
Betaxolol—Vision blurred—Epirubicin—thyroid cancer	0.000682	0.000762	CcSEcCtD
Betaxolol—Alopecia—Doxorubicin—thyroid cancer	0.000679	0.000759	CcSEcCtD
Betaxolol—Mental disorder—Doxorubicin—thyroid cancer	0.000673	0.000753	CcSEcCtD
Betaxolol—Ill-defined disorder—Epirubicin—thyroid cancer	0.000671	0.00075	CcSEcCtD
Betaxolol—Malnutrition—Doxorubicin—thyroid cancer	0.000669	0.000748	CcSEcCtD
Betaxolol—Erythema—Doxorubicin—thyroid cancer	0.000669	0.000748	CcSEcCtD
Betaxolol—Anaemia—Epirubicin—thyroid cancer	0.000668	0.000747	CcSEcCtD
Betaxolol—Tension—Doxorubicin—thyroid cancer	0.000657	0.000734	CcSEcCtD
Betaxolol—Dysgeusia—Doxorubicin—thyroid cancer	0.000655	0.000733	CcSEcCtD
Betaxolol—Malaise—Epirubicin—thyroid cancer	0.000652	0.000729	CcSEcCtD
Betaxolol—Nervousness—Doxorubicin—thyroid cancer	0.00065	0.000727	CcSEcCtD
Betaxolol—Vertigo—Epirubicin—thyroid cancer	0.00065	0.000726	CcSEcCtD
Betaxolol—Syncope—Epirubicin—thyroid cancer	0.000649	0.000725	CcSEcCtD
Betaxolol—Muscle spasms—Doxorubicin—thyroid cancer	0.000643	0.000719	CcSEcCtD
Betaxolol—Palpitations—Epirubicin—thyroid cancer	0.000639	0.000715	CcSEcCtD
Betaxolol—Loss of consciousness—Epirubicin—thyroid cancer	0.000636	0.000711	CcSEcCtD
Betaxolol—Cough—Epirubicin—thyroid cancer	0.000631	0.000706	CcSEcCtD
Betaxolol—Vision blurred—Doxorubicin—thyroid cancer	0.000631	0.000705	CcSEcCtD
Betaxolol—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000621	0.000694	CcSEcCtD
Betaxolol—Anaemia—Doxorubicin—thyroid cancer	0.000618	0.000692	CcSEcCtD
Betaxolol—Arthralgia—Epirubicin—thyroid cancer	0.000616	0.000688	CcSEcCtD
Betaxolol—Chest pain—Epirubicin—thyroid cancer	0.000616	0.000688	CcSEcCtD
Betaxolol—Myalgia—Epirubicin—thyroid cancer	0.000616	0.000688	CcSEcCtD
Betaxolol—Anxiety—Epirubicin—thyroid cancer	0.000614	0.000686	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000611	0.000684	CcSEcCtD
Betaxolol—Discomfort—Epirubicin—thyroid cancer	0.000608	0.00068	CcSEcCtD
Betaxolol—Malaise—Doxorubicin—thyroid cancer	0.000603	0.000675	CcSEcCtD
Betaxolol—Dry mouth—Epirubicin—thyroid cancer	0.000602	0.000673	CcSEcCtD
Betaxolol—Vertigo—Doxorubicin—thyroid cancer	0.000601	0.000672	CcSEcCtD
Betaxolol—Syncope—Doxorubicin—thyroid cancer	0.0006	0.000671	CcSEcCtD
Betaxolol—Confusional state—Epirubicin—thyroid cancer	0.000595	0.000665	CcSEcCtD
Betaxolol—Palpitations—Doxorubicin—thyroid cancer	0.000591	0.000661	CcSEcCtD
Betaxolol—Oedema—Epirubicin—thyroid cancer	0.00059	0.00066	CcSEcCtD
Betaxolol—Loss of consciousness—Doxorubicin—thyroid cancer	0.000588	0.000658	CcSEcCtD
Betaxolol—Infection—Epirubicin—thyroid cancer	0.000586	0.000656	CcSEcCtD
Betaxolol—Cough—Doxorubicin—thyroid cancer	0.000584	0.000653	CcSEcCtD
Betaxolol—Shock—Epirubicin—thyroid cancer	0.000581	0.000649	CcSEcCtD
Betaxolol—Nervous system disorder—Epirubicin—thyroid cancer	0.000579	0.000647	CcSEcCtD
Betaxolol—Thrombocytopenia—Epirubicin—thyroid cancer	0.000578	0.000646	CcSEcCtD
Betaxolol—Tachycardia—Epirubicin—thyroid cancer	0.000576	0.000644	CcSEcCtD
Betaxolol—Skin disorder—Epirubicin—thyroid cancer	0.000573	0.000641	CcSEcCtD
Betaxolol—Hyperhidrosis—Epirubicin—thyroid cancer	0.000571	0.000638	CcSEcCtD
Betaxolol—Myalgia—Doxorubicin—thyroid cancer	0.00057	0.000637	CcSEcCtD
Betaxolol—Chest pain—Doxorubicin—thyroid cancer	0.00057	0.000637	CcSEcCtD
Betaxolol—Arthralgia—Doxorubicin—thyroid cancer	0.00057	0.000637	CcSEcCtD
Betaxolol—Anxiety—Doxorubicin—thyroid cancer	0.000568	0.000635	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000566	0.000633	CcSEcCtD
Betaxolol—Discomfort—Doxorubicin—thyroid cancer	0.000563	0.000629	CcSEcCtD
Betaxolol—Anorexia—Epirubicin—thyroid cancer	0.000563	0.000629	CcSEcCtD
Betaxolol—Dry mouth—Doxorubicin—thyroid cancer	0.000557	0.000623	CcSEcCtD
Betaxolol—Hypotension—Epirubicin—thyroid cancer	0.000551	0.000617	CcSEcCtD
Betaxolol—Confusional state—Doxorubicin—thyroid cancer	0.000551	0.000616	CcSEcCtD
Betaxolol—Oedema—Doxorubicin—thyroid cancer	0.000546	0.000611	CcSEcCtD
Betaxolol—Infection—Doxorubicin—thyroid cancer	0.000543	0.000607	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000538	0.000601	CcSEcCtD
Betaxolol—Shock—Doxorubicin—thyroid cancer	0.000537	0.000601	CcSEcCtD
Betaxolol—Nervous system disorder—Doxorubicin—thyroid cancer	0.000536	0.000599	CcSEcCtD
Betaxolol—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000535	0.000598	CcSEcCtD
Betaxolol—Insomnia—Epirubicin—thyroid cancer	0.000534	0.000597	CcSEcCtD
Betaxolol—Tachycardia—Doxorubicin—thyroid cancer	0.000533	0.000596	CcSEcCtD
Betaxolol—Skin disorder—Doxorubicin—thyroid cancer	0.00053	0.000593	CcSEcCtD
Betaxolol—Paraesthesia—Epirubicin—thyroid cancer	0.00053	0.000593	CcSEcCtD
Betaxolol—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000528	0.00059	CcSEcCtD
Betaxolol—Dyspnoea—Epirubicin—thyroid cancer	0.000526	0.000588	CcSEcCtD
Betaxolol—Anorexia—Doxorubicin—thyroid cancer	0.000521	0.000582	CcSEcCtD
Betaxolol—Dyspepsia—Epirubicin—thyroid cancer	0.00052	0.000581	CcSEcCtD
Betaxolol—Decreased appetite—Epirubicin—thyroid cancer	0.000513	0.000574	CcSEcCtD
Betaxolol—Hypotension—Doxorubicin—thyroid cancer	0.00051	0.000571	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00051	0.00057	CcSEcCtD
Betaxolol—Fatigue—Epirubicin—thyroid cancer	0.000509	0.000569	CcSEcCtD
Betaxolol—Constipation—Epirubicin—thyroid cancer	0.000505	0.000564	CcSEcCtD
Betaxolol—Pain—Epirubicin—thyroid cancer	0.000505	0.000564	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000498	0.000556	CcSEcCtD
Betaxolol—Insomnia—Doxorubicin—thyroid cancer	0.000494	0.000552	CcSEcCtD
Betaxolol—Paraesthesia—Doxorubicin—thyroid cancer	0.00049	0.000548	CcSEcCtD
Betaxolol—Dyspnoea—Doxorubicin—thyroid cancer	0.000487	0.000544	CcSEcCtD
Betaxolol—Feeling abnormal—Epirubicin—thyroid cancer	0.000486	0.000544	CcSEcCtD
Betaxolol—Dyspepsia—Doxorubicin—thyroid cancer	0.000481	0.000537	CcSEcCtD
Betaxolol—Decreased appetite—Doxorubicin—thyroid cancer	0.000475	0.000531	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000471	0.000527	CcSEcCtD
Betaxolol—Fatigue—Doxorubicin—thyroid cancer	0.000471	0.000526	CcSEcCtD
Betaxolol—Urticaria—Epirubicin—thyroid cancer	0.000469	0.000524	CcSEcCtD
Betaxolol—Pain—Doxorubicin—thyroid cancer	0.000467	0.000522	CcSEcCtD
Betaxolol—Constipation—Doxorubicin—thyroid cancer	0.000467	0.000522	CcSEcCtD
Betaxolol—Body temperature increased—Epirubicin—thyroid cancer	0.000467	0.000522	CcSEcCtD
Betaxolol—Feeling abnormal—Doxorubicin—thyroid cancer	0.00045	0.000503	CcSEcCtD
Betaxolol—Hypersensitivity—Epirubicin—thyroid cancer	0.000435	0.000486	CcSEcCtD
Betaxolol—Urticaria—Doxorubicin—thyroid cancer	0.000434	0.000485	CcSEcCtD
Betaxolol—Body temperature increased—Doxorubicin—thyroid cancer	0.000432	0.000483	CcSEcCtD
Betaxolol—Asthenia—Epirubicin—thyroid cancer	0.000423	0.000473	CcSEcCtD
Betaxolol—Pruritus—Epirubicin—thyroid cancer	0.000418	0.000467	CcSEcCtD
Betaxolol—Diarrhoea—Epirubicin—thyroid cancer	0.000404	0.000452	CcSEcCtD
Betaxolol—Hypersensitivity—Doxorubicin—thyroid cancer	0.000402	0.00045	CcSEcCtD
Betaxolol—Asthenia—Doxorubicin—thyroid cancer	0.000392	0.000438	CcSEcCtD
Betaxolol—Dizziness—Epirubicin—thyroid cancer	0.00039	0.000436	CcSEcCtD
Betaxolol—Pruritus—Doxorubicin—thyroid cancer	0.000386	0.000432	CcSEcCtD
Betaxolol—Vomiting—Epirubicin—thyroid cancer	0.000375	0.00042	CcSEcCtD
Betaxolol—Diarrhoea—Doxorubicin—thyroid cancer	0.000374	0.000418	CcSEcCtD
Betaxolol—Rash—Epirubicin—thyroid cancer	0.000372	0.000416	CcSEcCtD
Betaxolol—Dermatitis—Epirubicin—thyroid cancer	0.000372	0.000416	CcSEcCtD
Betaxolol—Headache—Epirubicin—thyroid cancer	0.00037	0.000413	CcSEcCtD
Betaxolol—Dizziness—Doxorubicin—thyroid cancer	0.000361	0.000404	CcSEcCtD
Betaxolol—Nausea—Epirubicin—thyroid cancer	0.000351	0.000392	CcSEcCtD
Betaxolol—Vomiting—Doxorubicin—thyroid cancer	0.000347	0.000388	CcSEcCtD
Betaxolol—Rash—Doxorubicin—thyroid cancer	0.000344	0.000385	CcSEcCtD
Betaxolol—Dermatitis—Doxorubicin—thyroid cancer	0.000344	0.000385	CcSEcCtD
Betaxolol—Headache—Doxorubicin—thyroid cancer	0.000342	0.000383	CcSEcCtD
Betaxolol—Nausea—Doxorubicin—thyroid cancer	0.000324	0.000363	CcSEcCtD
